<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38336381</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1521-0103</ISSN><JournalIssue CitedMedium="Internet"><Volume>389</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>15</Day></PubDate></JournalIssue><Title>The Journal of pharmacology and experimental therapeutics</Title><ISOAbbreviation>J Pharmacol Exp Ther</ISOAbbreviation></Journal><ArticleTitle>Endothelial Extracellular Vesicles Enriched in microRNA-34a Predict New-Onset Diabetes in Coronavirus Disease 2019 (COVID-19) Patients: Novel Insights for Long COVID Metabolic Sequelae.</ArticleTitle><Pagination><StartPage>34</StartPage><EndPage>39</EndPage><MedlinePgn>34-39</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1124/jpet.122.001253</ELocationID><Abstract><AbstractText>Emerging evidence indicates that the relationship between coronavirus disease 2019 (COVID-19) and diabetes is 2-fold: 1) it is known that the presence of diabetes and other metabolic alterations poses a considerably high risk to develop a severe COVID-19; 2) patients who survived a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have an increased risk of developing new-onset diabetes. However, the mechanisms underlying this association are mostly unknown, and there are no reliable biomarkers to predict the development of new-onset diabetes. In the present study, we demonstrate that a specific microRNA (miR-34a) contained in circulating extracellular vesicles released by endothelial cells reliably predicts the risk of developing new-onset diabetes in COVID-19. This association was independent of age, sex, body mass index (BMI), hypertension, dyslipidemia, smoking status, and D-dimer. SIGNIFICANCE STATEMENT: We demonstrate for the first time that a specific microRNA (miR-34a) contained in circulating extracellular vesicles released by endothelial cells is able to reliably predict the risk of developing diabetes after having contracted coronavirus disease 2019 (COVID-19). This association was independent of age, sex, body mass index (BMI), hypertension, dyslipidemia, smoking status, and D-dimer. Our findings are also relevant when considering the emerging importance of post-acute sequelae of COVID-19, with systemic manifestations observed even months after viral negativization (long COVID).</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 by The American Society for Pharmacology and Experimental Therapeutics.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mone</LastName><ForeName>Pasquale</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-6267-5845</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Einstein-Sinai Diabetes Research Center, Fleischer Institute for Diabetes and Metabolism, Einstein Institute for Aging Research (P.M., S.S.J., J.G., U.K., A.L., F.V., G.S.) and Department of Molecular Pharmacology, Wilf Family Cardiovascular Research Institute, Einstein Institute for Neuroimmunology and Inflammation (G.S.), Albert Einstein College of Medicine, New York, New York; Department of Advanced Biomedical Sciences, International Translational Research and Medical Education, "Federico II" University, Naples, Italy (M.V.M., J.G., R.I., D.S., B.T., G.S.); Clinica Montevergine, Mercogliano, Avellino (P.M.); and COVID-19 Division, A.O.R.N. Ospedali dei Colli, Naples, Italy (A.C., G.F.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jankauskas</LastName><ForeName>Stanislovas S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Medicine, Einstein-Sinai Diabetes Research Center, Fleischer Institute for Diabetes and Metabolism, Einstein Institute for Aging Research (P.M., S.S.J., J.G., U.K., A.L., F.V., G.S.) and Department of Molecular Pharmacology, Wilf Family Cardiovascular Research Institute, Einstein Institute for Neuroimmunology and Inflammation (G.S.), Albert Einstein College of Medicine, New York, New York; Department of Advanced Biomedical Sciences, International Translational Research and Medical Education, "Federico II" University, Naples, Italy (M.V.M., J.G., R.I., D.S., B.T., G.S.); Clinica Montevergine, Mercogliano, Avellino (P.M.); and COVID-19 Division, A.O.R.N. Ospedali dei Colli, Naples, Italy (A.C., G.F.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manzi</LastName><ForeName>Maria Virginia</ForeName><Initials>MV</Initials><AffiliationInfo><Affiliation>Department of Medicine, Einstein-Sinai Diabetes Research Center, Fleischer Institute for Diabetes and Metabolism, Einstein Institute for Aging Research (P.M., S.S.J., J.G., U.K., A.L., F.V., G.S.) and Department of Molecular Pharmacology, Wilf Family Cardiovascular Research Institute, Einstein Institute for Neuroimmunology and Inflammation (G.S.), Albert Einstein College of Medicine, New York, New York; Department of Advanced Biomedical Sciences, International Translational Research and Medical Education, "Federico II" University, Naples, Italy (M.V.M., J.G., R.I., D.S., B.T., G.S.); Clinica Montevergine, Mercogliano, Avellino (P.M.); and COVID-19 Division, A.O.R.N. Ospedali dei Colli, Naples, Italy (A.C., G.F.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gambardella</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medicine, Einstein-Sinai Diabetes Research Center, Fleischer Institute for Diabetes and Metabolism, Einstein Institute for Aging Research (P.M., S.S.J., J.G., U.K., A.L., F.V., G.S.) and Department of Molecular Pharmacology, Wilf Family Cardiovascular Research Institute, Einstein Institute for Neuroimmunology and Inflammation (G.S.), Albert Einstein College of Medicine, New York, New York; Department of Advanced Biomedical Sciences, International Translational Research and Medical Education, "Federico II" University, Naples, Italy (M.V.M., J.G., R.I., D.S., B.T., G.S.); Clinica Montevergine, Mercogliano, Avellino (P.M.); and COVID-19 Division, A.O.R.N. Ospedali dei Colli, Naples, Italy (A.C., G.F.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coppola</LastName><ForeName>Antonietta</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Einstein-Sinai Diabetes Research Center, Fleischer Institute for Diabetes and Metabolism, Einstein Institute for Aging Research (P.M., S.S.J., J.G., U.K., A.L., F.V., G.S.) and Department of Molecular Pharmacology, Wilf Family Cardiovascular Research Institute, Einstein Institute for Neuroimmunology and Inflammation (G.S.), Albert Einstein College of Medicine, New York, New York; Department of Advanced Biomedical Sciences, International Translational Research and Medical Education, "Federico II" University, Naples, Italy (M.V.M., J.G., R.I., D.S., B.T., G.S.); Clinica Montevergine, Mercogliano, Avellino (P.M.); and COVID-19 Division, A.O.R.N. Ospedali dei Colli, Naples, Italy (A.C., G.F.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kansakar</LastName><ForeName>Urna</ForeName><Initials>U</Initials><Identifier Source="ORCID">0000-0001-5847-0521</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Einstein-Sinai Diabetes Research Center, Fleischer Institute for Diabetes and Metabolism, Einstein Institute for Aging Research (P.M., S.S.J., J.G., U.K., A.L., F.V., G.S.) and Department of Molecular Pharmacology, Wilf Family Cardiovascular Research Institute, Einstein Institute for Neuroimmunology and Inflammation (G.S.), Albert Einstein College of Medicine, New York, New York; Department of Advanced Biomedical Sciences, International Translational Research and Medical Education, "Federico II" University, Naples, Italy (M.V.M., J.G., R.I., D.S., B.T., G.S.); Clinica Montevergine, Mercogliano, Avellino (P.M.); and COVID-19 Division, A.O.R.N. Ospedali dei Colli, Naples, Italy (A.C., G.F.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Izzo</LastName><ForeName>Raffaele</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medicine, Einstein-Sinai Diabetes Research Center, Fleischer Institute for Diabetes and Metabolism, Einstein Institute for Aging Research (P.M., S.S.J., J.G., U.K., A.L., F.V., G.S.) and Department of Molecular Pharmacology, Wilf Family Cardiovascular Research Institute, Einstein Institute for Neuroimmunology and Inflammation (G.S.), Albert Einstein College of Medicine, New York, New York; Department of Advanced Biomedical Sciences, International Translational Research and Medical Education, "Federico II" University, Naples, Italy (M.V.M., J.G., R.I., D.S., B.T., G.S.); Clinica Montevergine, Mercogliano, Avellino (P.M.); and COVID-19 Division, A.O.R.N. Ospedali dei Colli, Naples, Italy (A.C., G.F.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fiorentino</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medicine, Einstein-Sinai Diabetes Research Center, Fleischer Institute for Diabetes and Metabolism, Einstein Institute for Aging Research (P.M., S.S.J., J.G., U.K., A.L., F.V., G.S.) and Department of Molecular Pharmacology, Wilf Family Cardiovascular Research Institute, Einstein Institute for Neuroimmunology and Inflammation (G.S.), Albert Einstein College of Medicine, New York, New York; Department of Advanced Biomedical Sciences, International Translational Research and Medical Education, "Federico II" University, Naples, Italy (M.V.M., J.G., R.I., D.S., B.T., G.S.); Clinica Montevergine, Mercogliano, Avellino (P.M.); and COVID-19 Division, A.O.R.N. Ospedali dei Colli, Naples, Italy (A.C., G.F.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lombardi</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Einstein-Sinai Diabetes Research Center, Fleischer Institute for Diabetes and Metabolism, Einstein Institute for Aging Research (P.M., S.S.J., J.G., U.K., A.L., F.V., G.S.) and Department of Molecular Pharmacology, Wilf Family Cardiovascular Research Institute, Einstein Institute for Neuroimmunology and Inflammation (G.S.), Albert Einstein College of Medicine, New York, New York; Department of Advanced Biomedical Sciences, International Translational Research and Medical Education, "Federico II" University, Naples, Italy (M.V.M., J.G., R.I., D.S., B.T., G.S.); Clinica Montevergine, Mercogliano, Avellino (P.M.); and COVID-19 Division, A.O.R.N. Ospedali dei Colli, Naples, Italy (A.C., G.F.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varzideh</LastName><ForeName>Fahimeh</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medicine, Einstein-Sinai Diabetes Research Center, Fleischer Institute for Diabetes and Metabolism, Einstein Institute for Aging Research (P.M., S.S.J., J.G., U.K., A.L., F.V., G.S.) and Department of Molecular Pharmacology, Wilf Family Cardiovascular Research Institute, Einstein Institute for Neuroimmunology and Inflammation (G.S.), Albert Einstein College of Medicine, New York, New York; Department of Advanced Biomedical Sciences, International Translational Research and Medical Education, "Federico II" University, Naples, Italy (M.V.M., J.G., R.I., D.S., B.T., G.S.); Clinica Montevergine, Mercogliano, Avellino (P.M.); and COVID-19 Division, A.O.R.N. Ospedali dei Colli, Naples, Italy (A.C., G.F.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sorriento</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medicine, Einstein-Sinai Diabetes Research Center, Fleischer Institute for Diabetes and Metabolism, Einstein Institute for Aging Research (P.M., S.S.J., J.G., U.K., A.L., F.V., G.S.) and Department of Molecular Pharmacology, Wilf Family Cardiovascular Research Institute, Einstein Institute for Neuroimmunology and Inflammation (G.S.), Albert Einstein College of Medicine, New York, New York; Department of Advanced Biomedical Sciences, International Translational Research and Medical Education, "Federico II" University, Naples, Italy (M.V.M., J.G., R.I., D.S., B.T., G.S.); Clinica Montevergine, Mercogliano, Avellino (P.M.); and COVID-19 Division, A.O.R.N. Ospedali dei Colli, Naples, Italy (A.C., G.F.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trimarco</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Medicine, Einstein-Sinai Diabetes Research Center, Fleischer Institute for Diabetes and Metabolism, Einstein Institute for Aging Research (P.M., S.S.J., J.G., U.K., A.L., F.V., G.S.) and Department of Molecular Pharmacology, Wilf Family Cardiovascular Research Institute, Einstein Institute for Neuroimmunology and Inflammation (G.S.), Albert Einstein College of Medicine, New York, New York; Department of Advanced Biomedical Sciences, International Translational Research and Medical Education, "Federico II" University, Naples, Italy (M.V.M., J.G., R.I., D.S., B.T., G.S.); Clinica Montevergine, Mercogliano, Avellino (P.M.); and COVID-19 Division, A.O.R.N. Ospedali dei Colli, Naples, Italy (A.C., G.F.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santulli</LastName><ForeName>Gaetano</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-7231-375X</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Einstein-Sinai Diabetes Research Center, Fleischer Institute for Diabetes and Metabolism, Einstein Institute for Aging Research (P.M., S.S.J., J.G., U.K., A.L., F.V., G.S.) and Department of Molecular Pharmacology, Wilf Family Cardiovascular Research Institute, Einstein Institute for Neuroimmunology and Inflammation (G.S.), Albert Einstein College of Medicine, New York, New York; Department of Advanced Biomedical Sciences, International Translational Research and Medical Education, "Federico II" University, Naples, Italy (M.V.M., J.G., R.I., D.S., B.T., G.S.); Clinica Montevergine, Mercogliano, Avellino (P.M.); and COVID-19 Division, A.O.R.N. Ospedali dei Colli, Naples, Italy (A.C., G.F.) gaetano.santulli@einsteinmed.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 DK123259</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK033823</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL159062</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL146691</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 HL144456</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Pharmacol Exp Ther</MedlineTA><NlmUniqueID>0376362</NlmUniqueID><ISSNLinking>0022-3565</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="Y">Diabetes Mellitus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="Y">Hypertension</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050171" MajorTopicYN="Y">Dyslipidemias</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>10</Day><Hour>13</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>9</Day><Hour>20</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38336381</ArticleId><ArticleId IdType="pmc">PMC10949163</ArticleId><ArticleId IdType="doi">10.1124/jpet.122.001253</ArticleId><ArticleId IdType="pii">jpet.122.001253</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abumayyaleh MN&#xfa;&#xf1;ez Gil IJViana-Llamas MCRaposeiras Roubin SRomero RAlfonso-Rodr&#xed;guez EUribarri AFeltes GBecerra-Mu&#xf1;oz VMSantoro F, et al. ; HOPE COVID-19 investigators (2023) Post-COVID-19 syndrome and diabetes mellitus: a propensity-matched analysis of the International HOPE-II COVID-19 Registry. Front Endocrinol (Lausanne) 14:1167087.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10227507</ArticleId><ArticleId IdType="pubmed">37260447</ArticleId></ArticleIdList></Reference><Reference><Citation>Accili D (2021) Can COVID-19 cause diabetes? Nat Metab 3:123&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8892570</ArticleId><ArticleId IdType="pubmed">33432203</ArticleId></ArticleIdList></Reference><Reference><Citation>Adebayo AVarzideh FWilson SGambardella JEacobacci MJankauskas SSDonkor KKansakar UTrimarco VMone P, et al. (2021) L-arginine and COVID-19: an update. Nutrients 13:3951.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8619186</ArticleId><ArticleId IdType="pubmed">34836206</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B (2021) High-dimensional characterization of post-acute sequelae of COVID-19. Nature 594:259&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfayez OM, Aldmasi KS, Alruwais NH, Bin Awad NM, Al Yami MS, Almohammed OA, Almutairi AR (2022) Incidence of diabetic ketoacidosis among pediatrics with type 1 diabetes prior to and during COVID-19 pandemic: a meta-analysis of observational studies. Front Endocrinol (Lausanne) 13:856958.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8959619</ArticleId><ArticleId IdType="pubmed">35355556</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali H, Abu-Farha M, Hofmann S (2023) Editorial: COVID-19 and diabetes, volume II. Front Endocrinol (Lausanne) 14:1136997.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9885184</ArticleId><ArticleId IdType="pubmed">36726739</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, Banerjee A (2021) Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ 372:n693.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett CEKoyama AKAlvarez PChow WLundeen EAPerrine CGPavkov MERolka DBWiltz JLBull-Otterson L, et al. (2022) Risk for newly diagnosed diabetes &gt;30 days after SARS-CoV-2 infection among persons aged &lt;18 years - United States, March 1, 2020-June 28, 2021. MMWR Morb Mortal Wkly Rep 71:59&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8757617</ArticleId><ArticleId IdType="pubmed">35025851</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellia C, Andreadi A, D&#x2019;Ippolito I, Scola L, Barraco S, Meloni M, Lauro D, Bellia A (2023) Prevalence and risk of new-onset diabetes mellitus after COVID-19: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 14:1215879.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10507325</ArticleId><ArticleId IdType="pubmed">37732118</ArticleId></ArticleIdList></Reference><Reference><Citation>Beltr&#xe1;n-Camacho LEslava-Alc&#xf3;n SRojas-Torres MS&#xe1;nchez-Morillo DMartinez-Nicol&#xe1;s MPMart&#xed;n-Bermejo Vde la Torre IGBerrocoso EMoreno JAMoreno-Luna R, et al. (2022) The serum of COVID-19 asymptomatic patients up-regulates proteins related to endothelial dysfunction and viral response in circulating angiogenic cells ex-vivo. Mol Med 28:40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8994070</ArticleId><ArticleId IdType="pubmed">35397534</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard I, Limonta D, Mahal LK, Hobman TC (2020) Endothelium infection and dysregulation by SARS-CoV-2: evidence and caveats in COVID-19. Viruses 13:29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7823949</ArticleId><ArticleId IdType="pubmed">33375371</ArticleId></ArticleIdList></Reference><Reference><Citation>Casciola-Rosen LThiemann DRAndrade FTrejo-Zambrano MILeonard EKSpangler JBSkinner NEBailey JYegnasubramanian SWang R, et al. (2022) IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function. JCI Insight 7:e158362.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9090251</ArticleId><ArticleId IdType="pubmed">35349483</ArticleId></ArticleIdList></Reference><Reference><Citation>Cefalu WT (2023) COVID-19 and rising incidence of diabetes: despite evolving data, an enigma still to be solved. Diabetes Care 46:913&#x2013;915.</Citation><ArticleIdList><ArticleId IdType="pubmed">37185693</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha S, Seo EH, Lee SH, Kim KS, Oh CS, Moon JS, Kim JK (2021) MicroRNA expression in extracellular vesicles from nasal lavage fluid in chronic rhinosinusitis. Biomedicines 9:471.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8145239</ArticleId><ArticleId IdType="pubmed">33925835</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W, Zhang F, Hou X, Xu H, Tang D (2022) Ameliorating role of microRNA-378 carried by umbilical cord mesenchymal stem cells-released extracellular vesicles in mesangial proliferative glomerulonephritis. Cell Commun Signal 20:28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8905735</ArticleId><ArticleId IdType="pubmed">35264186</ArticleId></ArticleIdList></Reference><Reference><Citation>Chourasia P, Goyal L, Kansal D, Roy S, Singh R, Mahata I, Sheikh AB, Shekhar R (2023) Risk of new-onset diabetes mellitus as a post-COVID-19 condition and possible mechanisms: a scoping review. J Clin Med 12:1159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9917823</ArticleId><ArticleId IdType="pubmed">36769807</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Agnillo FWalters KAXiao YSheng ZMScherler KPark JGygli SRosas LASadtler KKalish H, et al. (2021) Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19. Sci Transl Med 13:eabj7790.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11000440</ArticleId><ArticleId IdType="pubmed">34648357</ArticleId></ArticleIdList></Reference><Reference><Citation>Draznin BAroda VRBakris GBenson GBrown FMFreeman RGreen JHuang EIsaacs DKahan S, et al. ; American Diabetes Association Professional Practice Committee (2022) 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care 45 (Suppl 1):S17&#x2013;S38.</Citation><ArticleIdList><ArticleId IdType="pubmed">34964875</ArticleId></ArticleIdList></Reference><Reference><Citation>Esmaeili A, Hosseini S, Baghaban Eslaminejad M (2021) Engineered-extracellular vesicles as an optimistic tool for microRNA delivery for osteoarthritis treatment. Cell Mol Life Sci 78:79&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11072651</ArticleId><ArticleId IdType="pubmed">32601714</ArticleId></ArticleIdList></Reference><Reference><Citation>Fader KA, Zhang J, Menetski JP, Thadhani RI, Antman EM, Friedman GS, Ramaiah SK, Vaidya VS (2021) A biomarker-centric approach to drug discovery and development: lessons learned from the coronavirus disease 2019 pandemic. J Pharmacol Exp Ther 376:12&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11046728</ArticleId><ArticleId IdType="pubmed">33115823</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman EL, Savelieff MG, Hayek SS, Pennathur S, Kretzler M, Pop-Busui R (2020) COVID-19 and diabetes: a collision and collusion of two diseases. Diabetes 69:2549&#x2013;2565.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7679769</ArticleId><ArticleId IdType="pubmed">32938731</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiorentino G, Coppola A, Izzo R, Annunziata A, Bernardo M, Lombardi A, Trimarco V, Santulli G, Trimarco B (2021) Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis. EClinicalMedicine 40:101125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8428476</ArticleId><ArticleId IdType="pubmed">34522871</ArticleId></ArticleIdList></Reference><Reference><Citation>Fullerton JL, Cosgrove CC, Rooney RA, Work LM (2023) Extracellular vesicles and their microRNA cargo in ischaemic stroke. J Physiol 601:4907&#x2013;4921.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10952288</ArticleId><ArticleId IdType="pubmed">35421904</ArticleId></ArticleIdList></Reference><Reference><Citation>Gambardella J, Coppola A, Izzo R, Fiorentino G, Trimarco B, Santulli G (2021) Role of endothelial miR-24 in COVID-19 cerebrovascular events. Crit Care 25:306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8385482</ArticleId><ArticleId IdType="pubmed">34433473</ArticleId></ArticleIdList></Reference><Reference><Citation>Gambardella J, Jankauskas SS, D&#x2019;Ascia SL, Sardu C, Matarese A, Minicucci F, Mone P, Santulli G (2022) Glycation of ryanodine receptor in circulating lymphocytes predicts the response to cardiac resynchronization therapy. J Heart Lung Transplant 41:438&#x2013;441.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8977242</ArticleId><ArticleId IdType="pubmed">35042640</ArticleId></ArticleIdList></Reference><Reference><Citation>Gambardella JKansakar USardu CMessina VJankauskas SSMarfella RMaggi PWang XMone PPaolisso G, et al. (2023) Exosomal miR-145 and miR-885 regulate thrombosis in COVID-19. J Pharmacol Exp Ther 384:109&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9827505</ArticleId><ArticleId IdType="pubmed">35772782</ArticleId></ArticleIdList></Reference><Reference><Citation>Gambardella J, Khondkar W, Morelli MB, Wang X, Santulli G, Trimarco V (2020) Arginine and endothelial function. Biomedicines 8:277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7460461</ArticleId><ArticleId IdType="pubmed">32781796</ArticleId></ArticleIdList></Reference><Reference><Citation>Gambardella J, Santulli G (2021) What is linking COVID-19 and endothelial dysfunction? Updates on nanomedicine and bioengineering from the 2020 AHA Scientific Sessions. Eur Heart J Cardiovasc Pharmacother 7:e2&#x2013;e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7799225</ArticleId><ArticleId IdType="pubmed">33377481</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelzo MCacciapuoti SPinchera BDe Rosa ACernera GScial&#xf2; FComegna MMormile MFabbrocini GParrella R, et al. (2021) Further findings concerning endothelial damage in COVID-19 patients. Biomolecules 11:1368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8468524</ArticleId><ArticleId IdType="pubmed">34572581</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorchane A, Ach T, Sahli J, Abdelkrim AB, Mallouli M, Bellazreg F, Hachfi W, Chaieb MC, Ach K (2023) Uncovering the alarming rise of diabetic ketoacidosis during COVID-19 pandemic: a pioneer African study and review of literature. Front Endocrinol (Lausanne) 14:1234256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10410463</ArticleId><ArticleId IdType="pubmed">37564978</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu C, Zhang H, Gao Y (2021) Adipose mesenchymal stem cells-secreted extracellular vesicles containing microRNA-192 delays diabetic retinopathy by targeting ITGA1. J Cell Physiol 236:5036&#x2013;5051.</Citation><ArticleIdList><ArticleId IdType="pubmed">33325098</ArticleId></ArticleIdList></Reference><Reference><Citation>Haffke MFreitag HRudolf GSeifert MDoehner WScherbakov NHanitsch LWittke KBauer SKonietschke F, et al. (2022) Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS). J Transl Med 20:138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938726</ArticleId><ArticleId IdType="pubmed">35317812</ArticleId></ArticleIdList></Reference><Reference><Citation>Higashikuni Y, Liu W, Obana T, Sata M (2021) Pathogenic basis of thromboinflammation and endothelial injury in COVID-19: current findings and therapeutic implications. Int J Mol Sci 22:12081.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8584434</ArticleId><ArticleId IdType="pubmed">34769508</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CW, Yu AS, Song H, Park JS, Wu SS, Khang VK, Subject CC, Shen E (2022) Association between dexamethasone treatment after hospital discharge for patients with COVID-19 infection and rates of hospital readmission and mortality. JAMA Netw Open 5:e221455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8905383</ArticleId><ArticleId IdType="pubmed">35258575</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal FM, Lam K, Sounderajah V, Clarke JM, Ashrafian H, Darzi A (2021) Characteristics and predictors of acute and chronic post-COVID syndrome: a systematic review and meta-analysis. EClinicalMedicine 36:100899.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8141371</ArticleId><ArticleId IdType="pubmed">34036253</ArticleId></ArticleIdList></Reference><Reference><Citation>Izzo RPacella DTrimarco VManzi MVLombardi APiccinocchi RGallo PEsposito GLembo MPiccinocchi G, et al. (2023) Incidence of type 2 diabetes before and during the COVID-19 pandemic in Naples, Italy: a longitudinal cohort study. EClinicalMedicine 66:102345.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10746394</ArticleId><ArticleId IdType="pubmed">38143804</ArticleId></ArticleIdList></Reference><Reference><Citation>Jankauskas SSMone PAvvisato RVarzideh FDe Gennaro SSalemme LMacina GKansakar UCioppa AFrullone S, et al. (2023) miR-181c targets Parkin and SMAD7 in human cardiac fibroblasts: validation of differential microRNA expression in patients with diabetes and heart failure with preserved ejection fraction. Mech Ageing Dev 212:111818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10330534</ArticleId><ArticleId IdType="pubmed">37116731</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalici&#x144;ska EBiernat MRybka JZi&#x144;czuk AJanocha-Litwin JRosiek-Biegus MMorawska MWaszczuk-Gajda ADrozd-Soko&#x142;owska JSzukalski &#x141;, et al. (2021) Endothelial activation and stress index (EASIX) as an early predictor for mortality and overall survival in hematological and non-hematological patients with COVID-19: multicenter cohort study. J Clin Med 10:4373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8509351</ArticleId><ArticleId IdType="pubmed">34640390</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamrath CRosenbauer JEckert AJPappa AReschke FRohrer TRMonkemoller KWurm MHake KRaile K, et al. (2021) Incidence of COVID-19 and risk of diabetic ketoacidosis in new-onset type 1 diabetes. Pediatrics 148:e2021050856.</Citation><ArticleIdList><ArticleId IdType="pubmed">34011636</ArticleId></ArticleIdList></Reference><Reference><Citation>Kansakar U, Gambardella J, Varzideh F, Avvisato R, Jankauskas SS, Mone P, Matarese A, Santulli G (2022) miR-142 targets TIM-1 in human endothelial cells: potential implications for stroke, COVID-19, Zika, Ebola, dengue, and other viral infections. Int J Mol Sci 23:10242.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9499484</ArticleId><ArticleId IdType="pubmed">36142146</ArticleId></ArticleIdList></Reference><Reference><Citation>Kastora S, Patel M, Carter B, Delibegovic M, Myint PK (2022) Impact of diabetes on COVID-19 mortality and hospital outcomes from a global perspective: an umbrella systematic review and meta-analysis. Endocrinol Diabetes Metab 5:e00338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9094465</ArticleId><ArticleId IdType="pubmed">35441801</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazakou P, Lambadiari V, Ikonomidis I, Kountouri A, Panagopoulos G, Athanasopoulos S, Korompoki E, Kalomenidis I, Dimopoulos MA, Mitrakou A (2022) Diabetes and COVID-19; a bidirectional interplay. Front Endocrinol (Lausanne) 13:780663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8891603</ArticleId><ArticleId IdType="pubmed">35250853</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelliher SWeiss LCullivan SO&#x2019;Rourke EMurphy CAToolan SLennon &#xc1;Szklanna PBComer SPMacleod H, et al. (2022) Non-severe COVID-19 is associated with endothelial damage and hypercoagulability despite pharmacological thromboprophylaxis. J Thromb Haemost 20:1008&#x2013;1014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9305123</ArticleId><ArticleId IdType="pubmed">35102689</ArticleId></ArticleIdList></Reference><Reference><Citation>Khunti K, Del Prato S, Mathieu C, Kahn SE, Gabbay RA, Buse JB (2021) COVID-19, hyperglycemia, and new-onset diabetes. Diabetes Care 44:2645&#x2013;2655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8669536</ArticleId><ArticleId IdType="pubmed">34625431</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D, Alshuwaykh O, Sandhu KK, Dennis BB, Cholankeril G, Ahmed A (2022) Trends in all-cause and cause-specific mortality among individuals with diabetes before and during the COVID-19 pandemic in the U.S. Diabetes Care 45:e107&#x2013;e109.</Citation><ArticleIdList><ArticleId IdType="pubmed">35446372</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SH, Arora I, Hsia DS, Knowler WC, LeBlanc E, Mylonakis E, Pratley R, Pittas AG (2023) New-onset diabetes after COVID-19. J Clin Endocrinol Metab 108:e1164&#x2013;e1174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11009784</ArticleId><ArticleId IdType="pubmed">37207448</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai HYang MSun MPan BWang QWang JTian JDing GYang KSong X, et al. (2022) Risk of incident diabetes after COVID-19 infection: a systematic review and meta-analysis. Metabolism 137:155330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9546784</ArticleId><ArticleId IdType="pubmed">36220361</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Peng L, Gu W (2023) The published trend of studies on COVID-19 and diabetes: bibliometric analysis. Front Endocrinol (Lausanne) 14:1248676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10581025</ArticleId><ArticleId IdType="pubmed">37854183</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao TL, Chen YM, Tang KT, Chen PK, Liu HJ, Chen DY (2021) MicroRNA-223 inhibits neutrophil extracellular traps formation through regulating calcium influx and small extracellular vesicles transmission. Sci Rep 11:15676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8333426</ArticleId><ArticleId IdType="pubmed">34344968</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Li YP, Xiao LM, Chen LK, Zheng SY, Zeng EM, Xu CH (2021) Extracellular vesicles derived from M2 microglia reduce ischemic brain injury through microRNA-135a-5p/TXNIP/NLRP3 axis. Lab Invest 101:837&#x2013;850.</Citation><ArticleIdList><ArticleId IdType="pubmed">33875790</ArticleId></ArticleIdList></Reference><Reference><Citation>Loo J, Spittle DA, Newnham M (2021) COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms. Thorax 76:412&#x2013;420.</Citation><ArticleIdList><ArticleId IdType="pubmed">33408195</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Z, Yang KY, Huang Y, Lui KO (2022) Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications. J Mol Cell Cardiol 164:69&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8610843</ArticleId><ArticleId IdType="pubmed">34838588</ArticleId></ArticleIdList></Reference><Reference><Citation>Maldonado FMorales DD&#xed;az-Papapietro CVald&#xe9;s CFernandez CValls NLazo MEspinoza CGonz&#xe1;lez RGuti&#xe9;rrez R, et al. (2022) Relationship between endothelial and angiogenesis biomarkers envisage mortality in a prospective cohort of COVID-19 patients requiring respiratory support. Front Med (Lausanne) 9:826218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8966493</ArticleId><ArticleId IdType="pubmed">35372407</ArticleId></ArticleIdList></Reference><Reference><Citation>Metwally AA, Mehta P, Johnson BS, Nagarjuna A, Snyder MP (2021) COVID-19-induced new-onset diabetes: trends and technologies. Diabetes 70:2733&#x2013;2744.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8660988</ArticleId><ArticleId IdType="pubmed">34686519</ArticleId></ArticleIdList></Reference><Reference><Citation>Mone P, De Gennaro S, Moriello D, Frullone S, D&#x2019;Amelio R, Ferrante MNV, Marro A, Santulli G (2023a) Insulin resistance drives cognitive impairment in hypertensive pre-diabetic frail elders: the CENTENNIAL study. Eur J Prev Cardiol 30:1283&#x2013;1288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10480019</ArticleId><ArticleId IdType="pubmed">37196030</ArticleId></ArticleIdList></Reference><Reference><Citation>Mone P, Gambardella J, Wang X, Jankauskas SS, Matarese A, Santulli G (2021) miR-24 targets the transmembrane glycoprotein neuropilin-1 in human brain microvascular endothelial cells. Noncoding RNA 7:9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7931075</ArticleId><ArticleId IdType="pubmed">33540664</ArticleId></ArticleIdList></Reference><Reference><Citation>Mone PLombardi AKansakar UVarzideh FJankauskas SSPansini AMarzocco SDe Gennaro SFamiglietti MMacina G, et al. (2023b) Empagliflozin improves the microRNA signature of endothelial dysfunction in patients with heart failure with preserved ejection fraction and diabetes. J Pharmacol Exp Ther 384:116&#x2013;122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9827502</ArticleId><ArticleId IdType="pubmed">36549862</ArticleId></ArticleIdList></Reference><Reference><Citation>Montefusco LBen Nasr MD&#x2019;Addio FLoretelli CRossi APastore IDaniele GAbdelsalam AMaestroni ADell&#x2019;Acqua M, et al. (2021) Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat Metab 3:774&#x2013;785.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9931026</ArticleId><ArticleId IdType="pubmed">34035524</ArticleId></ArticleIdList></Reference><Reference><Citation>Montiel VLobysheva IG&#xe9;rard LVermeersch MPerez-Morga DCastelein TMesland JBHantson PCollienne CGruson D, et al. (2022) Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients. EBioMedicine 77:103893.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8865837</ArticleId><ArticleId IdType="pubmed">35219085</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelli MB, Shu J, Sardu C, Matarese A, Santulli G (2019) Cardiosomal microRNAs are essential in post-infarction myofibroblast phenoconversion. Int J Mol Sci 21:201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6982041</ArticleId><ArticleId IdType="pubmed">31892162</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayan KMV, Staimez LR (2022) Rising diabetes diagnosis in long COVID. Lancet Diabetes Endocrinol 10:298&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8937249</ArticleId><ArticleId IdType="pubmed">35325625</ArticleId></ArticleIdList></Reference><Reference><Citation>Nassar M, Nso N, Baraka B, Alfishawy M, Mohamed M, Nyabera A, Sachmechi I (2021) The association between COVID-19 and type 1 diabetes mellitus: a systematic review. Diabetes Metab Syndr 15:447&#x2013;454.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7872855</ArticleId><ArticleId IdType="pubmed">33592371</ArticleId></ArticleIdList></Reference><Reference><Citation>Naveed Z, Vel&#xe1;squez Garc&#xed;a HA, Wong S, Wilton J, McKee G, Mahmood B, Binka M, Rasali D, Janjua NZ (2023) Association of COVID-19 infection with incident diabetes. JAMA Netw Open 6:e238866.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10114057</ArticleId><ArticleId IdType="pubmed">37071420</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney LLRouten AGillies CEkezie WWelford AZhang AKaramchandani USimms-Williams NCassambai SArdavani A, et al. (2022) The prevalence and long-term health effects of long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClinicalMedicine 55:101762.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Otifi HM, Adiga BK (2022) Endothelial dysfunction in Covid-19 infection. Am J Med Sci 363:281&#x2013;287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8802031</ArticleId><ArticleId IdType="pubmed">35093394</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantea Stoian ABica ICSalmen TAl Mahmeed WAl-Rasadi KAl-Alawi KBanach MBanerjee YCeriello ACesur M, et al. ; Cardiometabolic Panel of International Experts on Syndemic COVID-19 (CAPISCO) (2024) New-onset diabetes mellitus in COVID-19: a scoping review. Diabetes Ther 15:33&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10786767</ArticleId><ArticleId IdType="pubmed">37751143</ArticleId></ArticleIdList></Reference><Reference><Citation>Papiewska-Paj&#x105;k I, Przygodzka P, Krzy&#x17c;anowski D, Soboska K, Szulc-Kie&#x142;bik I, Stasikowska-Kanicka O, Boncela J, W&#x105;growska-Danilewicz M, Kowalska MA (2021) Snail overexpression alters the microRNA content of extracellular vesicles released from HT29 colorectal cancer cells and activates pro-inflammatory state in vivo. Cancers (Basel) 13:172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7830966</ArticleId><ArticleId IdType="pubmed">33419021</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavani KCMeese TPascottini OBGuan XLin XPeelman LHamacher JVan Nieuwerburgh FDeforce DBoel A, et al. (2022) Hatching is modulated by microRNA-378a-3p derived from extracellular vesicles secreted by blastocysts. Proc Natl Acad Sci USA 119:e2122708119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8944274</ArticleId><ArticleId IdType="pubmed">35298333</ArticleId></ArticleIdList></Reference><Reference><Citation>Qeadan F, Tingey B, Egbert J, Pezzolesi MG, Burge MR, Peterson KA, Honda T (2022) The associations between COVID-19 diagnosis, type 1 diabetes, and the risk of diabetic ketoacidosis: a nationwide cohort from the US using the Cerner Real-World Data. PLoS One 17:e0266809.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9017888</ArticleId><ArticleId IdType="pubmed">35439266</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin ZLiu FBlair RWang CYang HMudd JCurrey JMIwanaga NHe JMi R, et al. (2021) Endothelial cell infection and dysfunction, immune activation in severe COVID-19. Theranostics 11:8076&#x2013;8091.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8315069</ArticleId><ArticleId IdType="pubmed">34335981</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmati M, Keshvari M, Mirnasuri S, Yon DK, Lee SW, Il Shin J, Smith L (2022) The global impact of COVID-19 pandemic on the incidence of pediatric new-onset type 1 diabetes and ketoacidosis: a systematic review and meta-analysis. J Med Virol 94:5112&#x2013;5127.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9350204</ArticleId><ArticleId IdType="pubmed">35831242</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathmann W, Kuss O, Kostev K (2022) Incidence of newly diagnosed diabetes after Covid-19. Diabetologia 65:949&#x2013;954.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8923743</ArticleId><ArticleId IdType="pubmed">35292829</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV, Misra A (2021) Post COVID-19 syndrome (&#x201c;long COVID&#x201d;) and diabetes: challenges in diagnosis and management. Diabetes Metab Syndr 15:102235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8317446</ArticleId><ArticleId IdType="pubmed">34384972</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubino FAmiel SAZimmet PAlberti GBornstein SEckel RHMingrone GBoehm BCooper MEChai Z, et al. (2020) New-onset diabetes in Covid-19. N Engl J Med 383:789&#x2013;790.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7304415</ArticleId><ArticleId IdType="pubmed">32530585</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabioni L, De Lorenzo A, Lamas C, Muccillo F, Castro-Faria-Neto HC, Estato V, Tibirica E (2021) Systemic microvascular endothelial dysfunction and disease severity in COVID-19 patients: evaluation by laser Doppler perfusion monitoring and cytokine/chemokine analysis. Microvasc Res 134:104119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7710468</ArticleId><ArticleId IdType="pubmed">33278457</ArticleId></ArticleIdList></Reference><Reference><Citation>Santoro LFalsetti LZaccone VNesci ATosato MGiupponi BSavastano MCMoroncini GGasbarrini ALandi F, et al. ; On Behalf Of Gemelli Against Covid-Post-Acute Care Study Group (2022) Impaired endothelial function in convalescent phase of COVID-19: a 3 month follow up observational prospective study. J Clin Med 11:1774.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8999944</ArticleId><ArticleId IdType="pubmed">35407382</ArticleId></ArticleIdList></Reference><Reference><Citation>Santulli G, Morelli MB, Gambardella J (2020) Is endothelial dysfunction the concealed cornerstone of COVID-19? Rapid response to: Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 368:m1091. DOI: 10.1136/bmj.m1091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1091</ArticleId><ArticleId IdType="pmc">PMC7190011</ArticleId><ArticleId IdType="pubmed">32217556</ArticleId></ArticleIdList></Reference><Reference><Citation>Santulli GPascale VFinelli RVisco VGiannotti RMassari AMorisco CCiccarelli MIllario MIaccarino G, et al. (2019) We are what we eat: impact of food from short supply chain on metabolic syndrome. J Clin Med 8:2061.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6947359</ArticleId><ArticleId IdType="pubmed">31771147</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R, Santulli G (2020) Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence. J Clin Med 9:1417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7290769</ArticleId><ArticleId IdType="pubmed">32403217</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathish T, Kapoor N, Cao Y, Tapp RJ, Zimmet P (2021) Proportion of newly diagnosed diabetes in COVID-19 patients: a systematic review and meta-analysis. Diabetes Obes Metab 23:870&#x2013;874.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753574</ArticleId><ArticleId IdType="pubmed">33245182</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherer PE, Kirwan JP, Rosen CJ (2022) Post-acute sequelae of COVID-19: a metabolic perspective. eLife 11:e78200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8942467</ArticleId><ArticleId IdType="pubmed">35318939</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitt JA, Ashraf AP, Becker DJ, Sen B (2022) Changes in type 2 diabetes trends in children and adolescents during the COVID-19 pandemic. J Clin Endocrinol Metab 107:e2777&#x2013;e2782.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8992346</ArticleId><ArticleId IdType="pubmed">35377436</ArticleId></ArticleIdList></Reference><Reference><Citation>Seitz A, Ong P (2022) Endothelial dysfunction in COVID-19: a potential predictor of long-COVID? Int J Cardiol 349:155&#x2013;156.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8610828</ArticleId><ArticleId IdType="pubmed">34838682</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvestro S, Gugliandolo A, Chiricosta L, Diomede F, Trubiani O, Bramanti P, Pizzicannella J, Mazzon E (2021) MicroRNA profiling of HL-1 cardiac cells-derived extracellular vesicles. Cells 10:273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7912193</ArticleId><ArticleId IdType="pubmed">33573156</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonoda Y, Kano F, Murata M (2021) Applications of cell resealing to reconstitute microRNA loading to extracellular vesicles. Sci Rep 11:2900.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7859222</ArticleId><ArticleId IdType="pubmed">33536479</ArticleId></ArticleIdList></Reference><Reference><Citation>Ssentongo P, Zhang Y, Witmer L, Chinchilli VM, Ba DM (2022) Association of COVID-19 with diabetes: a systematic review and meta-analysis. Sci Rep 12:20191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9684130</ArticleId><ArticleId IdType="pubmed">36418912</ArticleId></ArticleIdList></Reference><Reference><Citation>Steenblock CHassanein MKhan EGYaman MKamel MBarbir MLorke DERock JAEverett DBejtullah S, et al. (2022) Diabetes and COVID-19: short- and long-term consequences. Horm Metab Res 54:503&#x2013;509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9363150</ArticleId><ArticleId IdType="pubmed">35724689</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarnawski AS, Ahluwalia A (2022) Endothelial cells and blood vessels are major targets for COVID-19-induced tissue injury and spreading to various organs. World J Gastroenterol 28:275&#x2013;289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8771611</ArticleId><ArticleId IdType="pubmed">35110950</ArticleId></ArticleIdList></Reference><Reference><Citation>Trimarco V, Izzo R, Lombardi A, Coppola A, Fiorentino G, Santulli G (2023) Beneficial effects of L-arginine in patients hospitalized for COVID-19: new insights from a randomized clinical trial. Pharmacol Res 191:106702.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9928676</ArticleId><ArticleId IdType="pubmed">36804278</ArticleId></ArticleIdList></Reference><Reference><Citation>Trimarco VIzzo RPacella DTrama UManzi MVLombardi APiccinocchi RGallo PEsposito GPiccinocchi G, et al. (2024) Incidence of new-onset hypertension before, during, and after the COVID-19 pandemic: a 7-year longitudinal cohort study in a large population. BMC Medicine In press.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10949764</ArticleId><ArticleId IdType="pubmed">38500180</ArticleId></ArticleIdList></Reference><Reference><Citation>Trimarco VIzzo RZanforlin ATursi FScarpelli FSantus PPennisi APelaia GMussi CMininni S, et al. (2022) Endothelial dysfunction in long-COVID: new insights from the nationwide multicenter LINCOLN study. Pharmacol Res 185:106486.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9531936</ArticleId><ArticleId IdType="pubmed">36206959</ArticleId></ArticleIdList></Reference><Reference><Citation>Wander PL, Lowy E, Beste LA, Tulloch-Palomino L, Korpak A, Peterson AC, Kahn SE, Boyko EJ (2022) The incidence of diabetes among 2,777,768 veterans with and without recent SARS-CoV-2 infection. Diabetes Care 45:782&#x2013;788.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9016731</ArticleId><ArticleId IdType="pubmed">35085391</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Wang Y, Xiang Y, Ma J, Zhang H, Dai J, Hou Y, Yang Y, Ma J, Li H (2021) An in vitro study on extracellular vesicles from adipose-derived mesenchymal stem cells in protecting stress urinary incontinence through microRNA-93/F3 axis. Front Endocrinol (Lausanne) 12:693977.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8415505</ArticleId><ArticleId IdType="pubmed">34484115</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Morelli MB, Matarese A, Sardu C, Santulli G (2020) Cardiomyocyte-derived exosomal microRNA-92a mediates post-ischemic myofibroblast activation both in vitro and ex vivo. ESC Heart Fail 7:284&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7083461</ArticleId><ArticleId IdType="pubmed">31981320</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss A, Donnachie E, Beyerlein A, Ziegler AG, Bonifacio E (2023) Type 1 diabetes incidence and risk in children with a diagnosis of COVID-19. JAMA 329:2089&#x2013;2091.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10203966</ArticleId><ArticleId IdType="pubmed">37213115</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Al-Aly Z (2022) Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol 10:311&#x2013;321.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang HC, Rhee WJ (2021) Single step in situ detection of surface protein and microRNA in clustered extracellular vesicles using flow cytometry. J Clin Med 10:319.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7831033</ArticleId><ArticleId IdType="pubmed">33477255</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T, Mei Q, Zhang Z, Walline JH, Liu Y, Zhu H, Zhang S (2022) Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis. BMC Med 20:444.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9666960</ArticleId><ArticleId IdType="pubmed">36380329</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L, Qu H, Zhang Q, Hu J, Shou L (2023) Case report: fulminant type 1 diabetes following paucisymptomatic SARS-CoV-2 infection during late pregnancy. Front Endocrinol (Lausanne) 14:1168927.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10112664</ArticleId><ArticleId IdType="pubmed">37082120</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu LShe ZGCheng XQin JJZhang XJCai JLei FWang HXie JWang W, et al. (2020) Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab 31:1068&#x2013;1077.e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7252168</ArticleId><ArticleId IdType="pubmed">32369736</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>